Altimmune, Inc. (ALT)

Altimmune Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	31.47	135.12	111.1	190.3	115.92	8.96
Short-Term Investments	107.91	62.7	73.78	-	100.01	28.28
Cash & Short-Term Investments	139.38	197.82	184.88	190.3	215.92	37.24
Cash Growth	-0.99%	7.00%	-2.85%	-11.87%	479.81%	10.44%
Accounts Receivable	0.43	1.11	0.17	0.43	4.61	1.02
Other Receivables	2.91	3.74	2.37	5.41	7.76	0.63
Receivables	3.34	4.85	2.54	5.84	12.37	1.65
Prepaid Expenses	2.9	6.82	5.36	7.95	1.93	0.47
Restricted Cash	0.04	0.04	0.03	0.03	0.03	0.03
Other Current Assets	0.1	0.1	-	-	-	-
Total Current Assets	145.76	209.63	192.81	204.13	230.26	39.39
Property, Plant & Equipment	2.11	1.01	1.68	2.25	1.96	1.8
Other Intangible Assets	-	-	12.42	12.42	12.82	12.73
Other Long-Term Assets	-	-	0.02	0.07	0.07	0.13
Total Assets	147.86	210.64	206.93	218.87	245.12	54.06
Accounts Payable	1.13	2.07	4.8	2.03	0.61	0.02
Accrued Expenses	7.19	9.58	10.63	9.74	11.05	3.58
Current Portion of Leases	0.31	0.5	0.45	0.41	0.36	0.26
Current Income Taxes Payable	-	-	1.17	-	-	-
Current Unearned Revenue	-	-	-	-	-	0.06
Other Current Liabilities	-	-	-	6.09	-	-
Total Current Liabilities	8.64	12.14	17.05	18.28	12.02	3.92
Long-Term Leases	1.46	0.18	0.67	1.12	1.47	1.48
Long-Term Unearned Revenue	0.16	0.16	0.25	0.25	0.25	0.25
Other Long-Term Liabilities	4.23	4.06	3.66	0.08	5.5	2.88
Total Liabilities	14.49	16.54	21.64	19.73	19.24	8.54
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-In Capital	676.43	665.43	568.4	497.34	417.34	187.91
Retained Earnings	-538.21	-466.33	-377.88	-293.17	-186.42	-137.38
Comprehensive Income & Other	-4.85	-5	-5.23	-5.04	-5.04	-5.02
Total Common Equity	133.38	194.1	185.29	199.14	225.88	45.52
Shareholders' Equity	133.38	194.1	185.29	199.14	225.88	45.52
Total Liabilities & Equity	147.86	210.64	206.93	218.87	245.12	54.06
Total Debt	1.77	0.67	1.12	1.54	1.82	1.74
Net Cash (Debt)	137.61	197.14	183.76	188.77	214.1	35.5
Net Cash Growth	-1.70%	7.29%	-2.65%	-11.83%	503.16%	7.09%
Net Cash Per Share	2.03	3.70	3.92	4.57	8.35	2.70
Filing Date Shares Outstanding	71.12	70.9	49.28	42.92	36.98	15.13
Total Common Shares Outstanding	71.12	70.68	49.2	40.69	36.97	15.08
Working Capital	137.12	197.48	175.76	185.85	218.24	35.47
Book Value Per Share	1.88	2.75	3.77	4.89	6.11	3.02
Tangible Book Value	133.38	194.1	172.87	186.72	213.05	32.79
Tangible Book Value Per Share	1.88	2.75	3.51	4.59	5.76	2.17
Machinery	-	0.7	0.65	1.55	1.31	1.2
Leasehold Improvements	-	1.75	1.75	1.79	1.29	1.23

Source: S&P Capital IQ. Standard template. Financial Sources.